Fig. 5.

EAAT inhibition in the nTS decreases baseline cardiorespiratory function. A: representative example showing decreases in arterial pressure (AP), mean AP (MAP, superimposed on pulsatile AP trace), heart rate (HR), integrated splanchnic sympathetic nerve activity (SSNA), and integrated phrenic nerve activity (PhrNA) following microinjection of TBOA into the nTS. B: group data indicate that TBOA significantly decreased all cardiorespiratory parameters relative to baseline (BL). Note the partial to full recovery (Rec). *P < 0.05; **P < 0.01.